首页> 美国卫生研究院文献>Theranostics >Photodynamic therapy at ultra-low NIR laser power and X-Ray imaging using Cu3BiS3 nanocrystals
【2h】

Photodynamic therapy at ultra-low NIR laser power and X-Ray imaging using Cu3BiS3 nanocrystals

机译:使用Cu3BiS3纳米晶体以超低NIR激光功率进行光动力疗法和X射线成像

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Materials with efficient potential in imaging as well as therapy are gaining particular attention in current medical research. Photodynamic therapy (PDT) has been recently recognized as a promising treatment option for solid tumors. Still, most of the nanomaterial-based PDT modules either employ an additional photosensitizer or require high power laser sources. Also, they suffer from a lack of responsiveness in the near-infrared (NIR) region. Nanomaterials that could realize PDT independently (without any photosensitizer), at safe laser dose and in the deep tissue penetrative NIR region would definitely be better solid tumor treatment options.>Methods: Herein, Cu- and Bi-based bimetal chalcogenide (Cu3BiS3), with absorption in the NIR region was developed. High-performance PDT of cancer and high-contrast x-ray imaging of tumor were performed in vivo. Biocompatibility of the NCs was also assessed in vivo.>Results: The highlight of the results was the realization of ultra-low dose NIR laser-mediated PDT, which has not been achieved before, leading to complete tumor regression. This could be a breakthrough in providing a pain- and scar-less treatment option, especially for solid tumors and malignant/benign subcutaneous masses. Though the NCs are active in the photo-thermal therapy (PTT) regime as well, focus is given to the exciting aspect of extremely low power-induced PDT observed here.>Conclusion: Their extended in vivo biodistribution with commendable hemo- and histo-compatibilities, along with imaging and multi-therapeutic capabilities, project these Cu3BiS3 NCs as promising, prospective theranostic candidates.
机译:在当前的医学研究中,具有显着成像和治疗潜力的材料正受到特别关注。最近,光动力疗法(PDT)被公认为是针对实体瘤的有前途的治疗选择。尽管如此,大多数基于纳米材料的PDT模块要么采用附加的光敏剂,要么需要高功率激光源。而且,它们在近红外(NIR)区域缺乏响应能力。在安全的激光剂量和深层组织穿透性NIR区域可以独立实现PDT(不使用任何光敏剂)的纳米材料肯定是更好的实体瘤治疗选择。>方法:本文中,基于Cu和Bi的开发了在近红外区域具有吸收的双金属硫属元素化物(Cu3BiS3)。在体内进行了癌症的高性能PDT和肿瘤的高对比度X射线成像。还评估了NC的生物相容性。>结果:结果的重点是实现了超低剂量NIR激光介导的PDT,这是以前从未实现的,从而导致了肿瘤的完全消退。这在提供无痛无疤的治疗选择方面可能是一项突破,特别是对于实体瘤和恶性/良性皮下肿块。尽管NC在光热疗法(PTT)方面也很活跃,但此处重点关注的是极低功率诱导的PDT的令人兴奋的方面。>结论:值得称赞的血液和组织相容性,以及成像和多种治疗能力,将这些Cu3BiS3 NCs预测为有希望的,预期的治疗学候选者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号